• 1
    Hirsh J, Dalen JE, Anderson D et al. 5th American College of Chest Physicians Consensus Conference on Antithrombotic Therapy. Chest 2000; 114 (5 Suppl.): 445S470S.
  • 2
    Van Den Besselaar AM. Recommended method for reporting therapeutic control of oral anticoagulant therapy. Control of Anticoagulation Subcommittee of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Thromb Haemost 1990; 63: 3167.
  • 3
    International Committee for Standardization in Haematology, International Committee on Thrombosis and Haemostasis. ICSH/ICTH recommendations for reporting prothrombin time in oral anticoagulant control. Thromb Haemost 1985; 53: 1556.
  • 4
    Preston FE. Quality control and oral anticoagulation. Thromb Haemost 1995; 74: 51520.
  • 5
    Cortelazzo S, Finazzi G, Viero P et al. Thrombotic and hemorrhagic complications in patients with mechanical heart valve prosthesis attending an anticoagulation clinic. Thromb Haemost 1993; 69: 31620.
  • 6
    Jørgensen T, Jespersen J (eds). Antikoagulasjonsbehandling iNorden. Trondheim, Norway: SINTEF NIS. 1995.
  • 7
    Fihn SD. Aiming for safe anticoagulation. N Engl J Med 1995; 333: 545.
  • 8
    Ansell JE, Hughes R. Evolving models of warfarin management: anticoagulation clinics, patient self-monitoring, and patient self-management. Am Heart J 1996; 132: 1095100.
  • 9
    Fitzmaurice DA, Hobbs FD, Murray JA. Monitoring oral anticoagulation in primary care. BMJ 1996; 312: 14312.
  • 10
    Hobbs FD, Fitzmaurice DA. Where should oral anticoagulation monitoring take place?. Br J Gen Pract 1997; 47: 47980.
  • 11
    Steffensen FH, Kristensen K, Ejlersen E, Dahlerup JF, Sorensen HT. Major haemorrhagic complications during oral anticoagulant therapy in a Danish population-based cohort. J Intern Med 1997; 242: 497503.
  • 12
    Baglin T. Decentralised anticoagulant care. J Clin Pathol 1998; 51: 8990.
  • 13
    Logan EC, Auger MJ, Cotton P, Otter PI. Monitoring oral anticoagulation in primary care. Shared care can work. BMJ 1996; 313: 819.
  • 14
    Stange KC. Shared care. what mix of generalist and specialist care optimizes patient outcomes? J Fam Pract 1999; 48: 1779.
  • 15
    Hoskins PL, Fowler PM, Constantino M, Forrest J, Yue DK, Turtle JR. Sharing the care of diabetic patients between hospital and general practitioners: does it work? Diabet Med 1993; 10: 816.
  • 16
    Lassen JF. Oral anticoagulant therapy. A quality assessment. Danish Med Bull 1996; 43: 2901.
  • 17
    Holm T, Lassen JF, Husted S, Heickendorff L. Identification and surveillance of patients on oral anticoagulant therapy in a large geographical area-use of laboratory information systems. Thromb Haemost 1999; 82 (Suppl.): 8589.
  • 18
    Olesen F, Jensen PB, Grinsted P, Henriksen JS. General practitioners as advisers and coordinators in hospitals. Qual Health Care 1998; 7: 427.
  • 19
    Hutten BA, Prins MH, Redekop WK, Tijssen JG, Heisterkamp SH, Buller HR. Comparison of three methods to assess therapeutic quality control of treatment with vitamin K antagonists. Thromb Haemost 1999; 82: 12603.
  • 20
    Godtfredsen J, Hansen MS, Husted SE, Hjelms E, Jespersen J. Antithrombotic treatment in cardiovascular diseases. A report by a working group of the Danish Cardiologic Society and the Danish Society of Clinical Chemistry. Ugeskr Laeger 1997; 159 (Suppl. 3): 128.
  • 21
    Landefeld CS, Anderson PA, Goodnough LT et al. The bleeding severity index: validation and comparison to other methods for classifying bleeding complications of medical therapy. JClinEpidemiol 1989; 42: 7118.
  • 22
    Palareti G, Manotti CD, Angelo A et al. Thrombotic events during oral anticoagulant treatment: results of the inception-cohort, prospective, collaborative ISCOAT study: ISCOAT study group (Italian Study on Complications of Oral Anticoagulant Therapy). Thromb Haemost 1997; 78: 143843.
  • 23
    Cohen IA, Hutchison TA, Kirking DM, Shue ME. Evaluation of a pharmacist-managed anticoagulation clinic. J Clin Hosp Pharm 1985; 10: 16775.
  • 24
    Garabedian-Ruffalo SM, Gray DR, Sax MJ, Ruffalo RL. Retrospective evaluation of a pharmacist-managed warfarin anticoagulation clinic. Am J Hosp Pharm 1985; 42: 3048.
  • 25
    Wilt VM, Gums JG, Ahmed OI, Moore LM. Outcome analysis of a pharmacist-managed anticoagulation service. Pharmacotherapy 1995; 15: 7329.
  • 26
    Holden J, Holden K. Comparative effectiveness of general practitioner versus pharmacist dosing of patients requiring anticoagulation in the community. J Clin Pharm Ther 2000; 25: 4954.
  • 27
    Chiquette E, Amato MG, Bussey HI. Comparison of an anticoagulation clinic with usual medical care: anticoagulation control, patient outcomes, and health care costs. Arch Intern Med 1998; 158: 16417.
  • 28
    Galloway MJ, Foggin JJ, Dixon S. Introduction of computer assisted control of oral anticoagulation in general practice. JClin Pathol 1995; 48: 11446.
  • 29
    Sawicki PT. A structured teaching and self-management program for patients receiving oral anticoagulation: a randomized controlled trial. Working Group for the Study of Patient Self-Management of Oral Anticoagulation. JAMA 1999; 281: 14550.
  • 30
    Cromheecke ME, Levi M, Colly LP et al. Oral anticoagulation self-management and management by a specialist anticoagulation clinic: a randomised cross-over comparison. Lancet 2000; 356: 97102.
  • 31
    Kortke H, Korfer R. International normalized ratio self-management after mechanical heart valve replacement: is an early start advantageous? Ann Thorac Surg 2001; 72: 448.
  • 32
    Landefeld CS, Goldman L. Major bleeding in outpatients treated with warfarin. incidence and prediction by factors known at the start of outpatient therapy. Am J Med 1989; 87: 14452.